Trial Outcomes & Findings for Assessing Ventilator Safety in Patients on Pressure-Support Ventilation (NCT NCT05125952)

NCT ID: NCT05125952

Last Updated: 2025-10-15

Results Overview

Driving pressure in centimeters of water measured with inspiratory hold on Servo Ventilator in pressure-support ventilation.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

16 participants

Primary outcome timeframe

Study day 1

Results posted on

2025-10-15

Participant Flow

Participants were randomized to different sequences of receiving the 4 different measurement methods: Viasys Avea Ventilator, Philips Respironics NM3 device, Servo U ventilator, and Vyaire SmartCath adult nasogastric tube with Esophageal balloon.

Participant milestones

Participant milestones
Measure
Acute Respiratory Failure
Patients with acute respiratory failure managed with pressure-support ventilation. Viasys Avea Ventilator: Measuring dynamic airway driving pressure and static airway driving pressure during pressure support breath, and static airway driving pressure during a volume control breath. Measuring airway occlusion pressure during pressure support breath. Philips Respironics NM3 device: Measuring static airway driving pressure during pressure support breath Servo U ventilator: Measuring static airway driving pressure and p0.1 during pressure support breath. Vyaire SmartCath adult nasogastric tube with Esophageal balloon: Measuring static and dynamic esophageal driving pressure during pressure support breath, and esophogeal pressure change during airway occlusion maneuver.
Overall Study
STARTED
16
Overall Study
Viasys Avea Ventilator
15
Overall Study
Philips Respironics NM3 Device
15
Overall Study
Servo U Ventilator
15
Overall Study
Vyaire SmartCath Adult Nasogastric Tube With Esophageal Balloon
15
Overall Study
COMPLETED
15
Overall Study
NOT COMPLETED
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Acute Respiratory Failure
Patients with acute respiratory failure managed with pressure-support ventilation. Viasys Avea Ventilator: Measuring dynamic airway driving pressure and static airway driving pressure during pressure support breath, and static airway driving pressure during a volume control breath. Measuring airway occlusion pressure during pressure support breath. Philips Respironics NM3 device: Measuring static airway driving pressure during pressure support breath Servo U ventilator: Measuring static airway driving pressure and p0.1 during pressure support breath. Vyaire SmartCath adult nasogastric tube with Esophageal balloon: Measuring static and dynamic esophageal driving pressure during pressure support breath, and esophogeal pressure change during airway occlusion maneuver.
Overall Study
Physician Decision
1

Baseline Characteristics

Assessing Ventilator Safety in Patients on Pressure-Support Ventilation

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Acute Respiratory Failure
n=15 Participants
Patients with acute respiratory failure managed with pressure-support ventilation. Viasys Avea Ventilator: Measuring dynamic airway driving pressure and static airway driving pressure during pressure support breath, and static airway driving pressure during a volume control breath. Measuring airway occlusion pressure during pressure support breath. Philips Respironics NM3 device: Measuring static airway driving pressure during pressure support breath Servo U ventilator: Measuring static airway driving pressure and p0.1 during pressure support breath. Vyaire SmartCath adult nasogastric tube with Esophageal balloon: Measuring static and dynamic esophageal driving pressure during pressure support breath, and esophogeal pressure change during airway occlusion maneuver.
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
8 Participants
n=5 Participants
Age, Categorical
>=65 years
7 Participants
n=5 Participants
Age, Continuous
63 years
n=5 Participants
Sex: Female, Male
Female
6 Participants
n=5 Participants
Sex: Female, Male
Male
9 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
13 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=5 Participants
Race (NIH/OMB)
White
10 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
n=5 Participants
Region of Enrollment
United States
15 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Study day 1

Driving pressure in centimeters of water measured with inspiratory hold on Servo Ventilator in pressure-support ventilation.

Outcome measures

Outcome measures
Measure
Acute Respiratory Failure
n=15 Participants
Patients with acute respiratory failure managed with pressure-support ventilation. Viasys Avea Ventilator: Measuring dynamic airway driving pressure and static airway driving pressure during pressure support breath, and static airway driving pressure during a volume control breath. Measuring airway occlusion pressure during pressure support breath. Philips Respironics NM3 device: Measuring static airway driving pressure during pressure support breath Servo U ventilator: Measuring static airway driving pressure and p0.1 during pressure support breath. Vyaire SmartCath adult nasogastric tube with Esophageal balloon: Measuring static and dynamic esophageal driving pressure during pressure support breath, and esophogeal pressure change during airway occlusion maneuver.
Respiratory System Driving Pressure Measure by Servo Ventilator (DPrs-servo)
12.3 centimeters of water
Standard Deviation 2.9

PRIMARY outcome

Timeframe: Study day 1

Population: Not measured in 6 patients after Philips announced discontinuation of support for NM3.

Driving pressure in centimeters of water measured with Phillips Respironics NM3 device in pressure-support ventilation.

Outcome measures

Outcome measures
Measure
Acute Respiratory Failure
n=9 Participants
Patients with acute respiratory failure managed with pressure-support ventilation. Viasys Avea Ventilator: Measuring dynamic airway driving pressure and static airway driving pressure during pressure support breath, and static airway driving pressure during a volume control breath. Measuring airway occlusion pressure during pressure support breath. Philips Respironics NM3 device: Measuring static airway driving pressure during pressure support breath Servo U ventilator: Measuring static airway driving pressure and p0.1 during pressure support breath. Vyaire SmartCath adult nasogastric tube with Esophageal balloon: Measuring static and dynamic esophageal driving pressure during pressure support breath, and esophogeal pressure change during airway occlusion maneuver.
Respiratory System Driving Pressure Measure by Respironics NM3 Device (DPrs-NM3)
8.8 centimeters of water
Standard Deviation 3.2

PRIMARY outcome

Timeframe: Study day 1

Maximum negative airway pressure in centimeters of water during an airway occlusion maneuver. The Vyaire SmartCath adult nasogastric tube with esophageal balloon was used to measure esophogeal pressure change during airway occlusion maneuver.

Outcome measures

Outcome measures
Measure
Acute Respiratory Failure
n=15 Participants
Patients with acute respiratory failure managed with pressure-support ventilation. Viasys Avea Ventilator: Measuring dynamic airway driving pressure and static airway driving pressure during pressure support breath, and static airway driving pressure during a volume control breath. Measuring airway occlusion pressure during pressure support breath. Philips Respironics NM3 device: Measuring static airway driving pressure during pressure support breath Servo U ventilator: Measuring static airway driving pressure and p0.1 during pressure support breath. Vyaire SmartCath adult nasogastric tube with Esophageal balloon: Measuring static and dynamic esophageal driving pressure during pressure support breath, and esophogeal pressure change during airway occlusion maneuver.
Airway Occlusion Test (AOC)
17.4 centimeters of water
Standard Deviation 10.1

PRIMARY outcome

Timeframe: Study day 1

Airway driving pressure in centimeters of water measured with inspiratory hold in volume control/assist control.

Outcome measures

Outcome measures
Measure
Acute Respiratory Failure
n=15 Participants
Patients with acute respiratory failure managed with pressure-support ventilation. Viasys Avea Ventilator: Measuring dynamic airway driving pressure and static airway driving pressure during pressure support breath, and static airway driving pressure during a volume control breath. Measuring airway occlusion pressure during pressure support breath. Philips Respironics NM3 device: Measuring static airway driving pressure during pressure support breath Servo U ventilator: Measuring static airway driving pressure and p0.1 during pressure support breath. Vyaire SmartCath adult nasogastric tube with Esophageal balloon: Measuring static and dynamic esophageal driving pressure during pressure support breath, and esophogeal pressure change during airway occlusion maneuver.
Respiratory System Driving Pressure Measured During Volume Control Breath.
12.3 centimeters of water
Standard Deviation 3.4

PRIMARY outcome

Timeframe: Study day 1

Population: Not measured in 7 patients who could not have esophageal balloon placed.

Transpulmonary driving pressure in centimeters of water measured via esophageal balloon with inspiratory hold in volume control/assist control.

Outcome measures

Outcome measures
Measure
Acute Respiratory Failure
n=8 Participants
Patients with acute respiratory failure managed with pressure-support ventilation. Viasys Avea Ventilator: Measuring dynamic airway driving pressure and static airway driving pressure during pressure support breath, and static airway driving pressure during a volume control breath. Measuring airway occlusion pressure during pressure support breath. Philips Respironics NM3 device: Measuring static airway driving pressure during pressure support breath Servo U ventilator: Measuring static airway driving pressure and p0.1 during pressure support breath. Vyaire SmartCath adult nasogastric tube with Esophageal balloon: Measuring static and dynamic esophageal driving pressure during pressure support breath, and esophogeal pressure change during airway occlusion maneuver.
Transpulmonary Driving Pressure Measured During Volume Control Breath.
9.5 centimeters of water
Standard Deviation 3.6

SECONDARY outcome

Timeframe: Index hospitalization (up to 28 days)

Population: Not measured in 3 patients who were never extubated.

Number of days receiving mechanical ventilation

Outcome measures

Outcome measures
Measure
Acute Respiratory Failure
n=12 Participants
Patients with acute respiratory failure managed with pressure-support ventilation. Viasys Avea Ventilator: Measuring dynamic airway driving pressure and static airway driving pressure during pressure support breath, and static airway driving pressure during a volume control breath. Measuring airway occlusion pressure during pressure support breath. Philips Respironics NM3 device: Measuring static airway driving pressure during pressure support breath Servo U ventilator: Measuring static airway driving pressure and p0.1 during pressure support breath. Vyaire SmartCath adult nasogastric tube with Esophageal balloon: Measuring static and dynamic esophageal driving pressure during pressure support breath, and esophogeal pressure change during airway occlusion maneuver.
Duration of Mechanical Ventilation
12.4 days
Standard Deviation 9.1

SECONDARY outcome

Timeframe: Index hospitalization (up to 28 days)

Population: Not measured for 5 patients who did not survive to ICU discharge.

Number of days admitted to intensive care unit

Outcome measures

Outcome measures
Measure
Acute Respiratory Failure
n=10 Participants
Patients with acute respiratory failure managed with pressure-support ventilation. Viasys Avea Ventilator: Measuring dynamic airway driving pressure and static airway driving pressure during pressure support breath, and static airway driving pressure during a volume control breath. Measuring airway occlusion pressure during pressure support breath. Philips Respironics NM3 device: Measuring static airway driving pressure during pressure support breath Servo U ventilator: Measuring static airway driving pressure and p0.1 during pressure support breath. Vyaire SmartCath adult nasogastric tube with Esophageal balloon: Measuring static and dynamic esophageal driving pressure during pressure support breath, and esophogeal pressure change during airway occlusion maneuver.
Duration of Intensive Care Unit Admission
17.2 days
Standard Deviation 6.9

SECONDARY outcome

Timeframe: Index hospitalization (up to 28 days)

Population: Not measured in 8 patients who did not survive to hospital discharge.

Number of days admitted to hospital

Outcome measures

Outcome measures
Measure
Acute Respiratory Failure
n=7 Participants
Patients with acute respiratory failure managed with pressure-support ventilation. Viasys Avea Ventilator: Measuring dynamic airway driving pressure and static airway driving pressure during pressure support breath, and static airway driving pressure during a volume control breath. Measuring airway occlusion pressure during pressure support breath. Philips Respironics NM3 device: Measuring static airway driving pressure during pressure support breath Servo U ventilator: Measuring static airway driving pressure and p0.1 during pressure support breath. Vyaire SmartCath adult nasogastric tube with Esophageal balloon: Measuring static and dynamic esophageal driving pressure during pressure support breath, and esophogeal pressure change during airway occlusion maneuver.
Duration of Hospital Admission
28 days
Standard Deviation 0.8

SECONDARY outcome

Timeframe: Index hospitalization (up to 28 days)

Number of days free from mechanical ventilation

Outcome measures

Outcome measures
Measure
Acute Respiratory Failure
n=15 Participants
Patients with acute respiratory failure managed with pressure-support ventilation. Viasys Avea Ventilator: Measuring dynamic airway driving pressure and static airway driving pressure during pressure support breath, and static airway driving pressure during a volume control breath. Measuring airway occlusion pressure during pressure support breath. Philips Respironics NM3 device: Measuring static airway driving pressure during pressure support breath Servo U ventilator: Measuring static airway driving pressure and p0.1 during pressure support breath. Vyaire SmartCath adult nasogastric tube with Esophageal balloon: Measuring static and dynamic esophageal driving pressure during pressure support breath, and esophogeal pressure change during airway occlusion maneuver.
Ventilator Free Days
16 days
Interval 0.0 to 21.5

SECONDARY outcome

Timeframe: Index hospitalization (up to 28 days)

Survival to discharge

Outcome measures

Outcome measures
Measure
Acute Respiratory Failure
n=15 Participants
Patients with acute respiratory failure managed with pressure-support ventilation. Viasys Avea Ventilator: Measuring dynamic airway driving pressure and static airway driving pressure during pressure support breath, and static airway driving pressure during a volume control breath. Measuring airway occlusion pressure during pressure support breath. Philips Respironics NM3 device: Measuring static airway driving pressure during pressure support breath Servo U ventilator: Measuring static airway driving pressure and p0.1 during pressure support breath. Vyaire SmartCath adult nasogastric tube with Esophageal balloon: Measuring static and dynamic esophageal driving pressure during pressure support breath, and esophogeal pressure change during airway occlusion maneuver.
In-hospital Survival
7 Participants

Adverse Events

Acute Respiratory Failure

Serious events: 1 serious events
Other events: 0 other events
Deaths: 8 deaths

Serious adverse events

Serious adverse events
Measure
Acute Respiratory Failure
n=15 participants at risk
Patients with acute respiratory failure managed with pressure-support ventilation. Viasys Avea Ventilator: Measuring dynamic airway driving pressure and static airway driving pressure during pressure support breath, and static airway driving pressure during a volume control breath. Measuring airway occlusion pressure during pressure support breath. Philips Respironics NM3 device: Measuring static airway driving pressure during pressure support breath Servo U ventilator: Measuring static airway driving pressure and p0.1 during pressure support breath. Vyaire SmartCath adult nasogastric tube with Esophageal balloon: Measuring static and dynamic esophageal driving pressure during pressure support breath, and esophogeal pressure change during airway occlusion maneuver.
Nervous system disorders
Agitation
6.7%
1/15 • Number of events 1 • 28 days

Other adverse events

Adverse event data not reported

Additional Information

Elias Pratt

Duke University School of Medicine

Phone: 919-684-8111

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place